These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8031308)

  • 1. A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture.
    Strobl JS; Peterson VA; Woodfork KA
    Biochem Pharmacol; 1994 Jun; 47(12):2157-61. PubMed ID: 8031308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
    Strobl JS; Peterson VA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):186-93. PubMed ID: 1403784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
    Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
    Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status.
    Jacobs E; Bulpitt PC; Coutts IG; Robertson JF
    Anticancer Drugs; 2000 Feb; 11(2):63-8. PubMed ID: 10789587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
    Borras M; Jin L; Bouhoute A; Legros N; Leclercq G
    Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D.
    Mullick A; Chambon P
    Cancer Res; 1990 Jan; 50(2):333-8. PubMed ID: 2295073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
    Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
    Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
    He FJ; Wang J; Niu JZ; Wang JF
    Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin modulates Akt activity in human breast cancer cell lines.
    Coticchia CM; Revankar CM; Deb TB; Dickson RB; Johnson MD
    Breast Cancer Res Treat; 2009 Jun; 115(3):545-60. PubMed ID: 18587642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
    Musgrove EA; Wakeling AE; Sutherland RL
    Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction.
    Toma S; Isnardi L; Raffo P; Dastoli G; De Francisci E; Riccardi L; Palumbo R; Bollag W
    Int J Cancer; 1997 Mar; 70(5):619-27. PubMed ID: 9052765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
    Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
    Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
    Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA; Greene GL; Lippman ME
    Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.